The global STD home testing market is anticipated to grow at a considerable CAGR of around 4.7% during the forecast period (2022-2028). More than 30 different bacteria, viruses, and parasites are transmitted through sexual contact. Eight of these pathogens are linked to the greatest incidence of sexually transmitted disease, which include syphilis, gonorrhea, Chlamydia, trichomoniasis, hepatitis B, herpes simplex virus, HIV, and human papillomavirus(HPV). According to the National Center for HIV, in 2020, women aged 20 to 24 years had the highest rate of reported cases of chlamydia 3,729.6 per, followed by those aged 15 to 19 years 2,857.9 and 25 to 29 years 1,548.0. Among men, those aged 20 to 24 years had the highest rate of reported cases of chlamydia 1,627.3, followed by those aged 25 to 29 years 988.3, and 15 to 19 years 846.3. moreover, from 2019 to 2020, the gonorrhea rate among women increased 14.7% from 152.1 to 174.5 and the rate among men increased 6.6% from 223.7 to 238.5. owing to the rise in the number of various STD infections in men and women, the demand for global STDs home testing continues to remain high during the forecast period.
Browse the full report description of “Global STD Home Testing Market Size, Share & Trends Analysis Report by Disease Type (Chlamydia, Syphilis, Gonorrhea, Herpes Simplex Virus, Human Papilloma Virus, Human Immunodeficiency Virus, Others) by Sample Type (Blood-Based, Oral-Fluid Based, Urine Based, Other Body Fluid Based) Forecast 2022-2028” at https://www.omrglobal.com/industry-reports/std-home-testing-market
The acquisitions and new launches being carried out by key market players allow them to reach additional markets, including new countries and platforms. For instance, in March 2021, the US FDA announced the approval of Binx Heath IO CT/NG assay at point of care settings such as in physician offices, community-based clinics, urgent care settings, and other patient care settings. The point of care setting assists in providing quick and appropriate treatment for sexually transmitted infections.
Market Coverage
• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2021-2028
• Segment Covered- by disease, by sample
• Regions Covered- North America, Europe, Asia-Pacific, Rest of the World
• Competitive Landscape- are Biosure (UK), Ltd., Everlywell, Inc., JAL Medical (Singapore) Pvt Ltd., Mylab Discovery Solutions Pvt. Ltd., and others.
Key questions addressed by the report
• What is the market growth rate?
• Which segment/region dominates the market in the base year?
• Which segment/region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
o Recovery Timeline
o Deviation from the pre-COVID forecast
o Most affected region/segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?
Global STD Home Testing Market– Segmentation
By Disease
• Chlamydia
• Syphilis
• Gonorrhea
• Herpes Simplex Virus
• Human Papilloma Virus
• Human Immunodeficiency Virus
• Others
By Sample
• Blood Based
• Oral- Fluid Based
• Urine- Based
• Other Body Fluid Based
Global STD Home Testing Market by Region
North America
• US
• Canada
Europe
• Germany
• United Kingdom
• France
• Spain
• Italy
• Rest of Europe
Asia-Pacific
• China
• Japan
• India
• Rest of Asia-Pacific
Rest of the World
• Middle East & Africa
• Latin America
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/std-home-testing-market